Lenalidomide
DrugBank ID: DB00480
Summary
| Metric | Value |
|---|---|
| Total Predictions | 51 |
| KG+DL (Dual Validated) | 3 |
| DL Only | 47 |
| KG Only | 1 |
Predictions
| Indication | Score | Source |
|---|---|---|
| myeloid leukemia | 0.9949 | DL |
| myelodysplastic syndrome | 0.9945 | KG+DL |
| unclassified myelodysplastic syndrome | 0.9943 | DL |
| refractory cytopenia of childhood | 0.9935 | DL |
| aregenerative anemia | 0.9932 | DL |
| severe congenital hypochromic anemia with ringed sideroblasts | 0.9928 | DL |
| partial deletion of the long arm of chromosome 5 | 0.9927 | DL |
| lymphosarcoma | 0.9812 | KG+DL |
| lymph node cancer | 0.9782 | DL |
| blast phase chronic myelogenous leukemia, BCR-ABL1 positive | 0.9674 | DL |
| ganglioneuroblastoma (disease) | 0.9597 | DL |
| acute lymphoblastic leukemia (disease) | 0.9593 | DL |
| vertebral anomalies and variable endocrine and T-cell dysfunction | 0.9569 | DL |
| neuroblastoma | 0.9556 | DL |
| retroperitoneal neoplasm | 0.9548 | DL |
| indolent plasma cell myeloma | 0.9483 | DL |
| plasma cell myeloma | 0.9477 | KG+DL |
| Ewing sarcoma | 0.9373 | DL |
| acute lymphoblastic/lymphocytic leukemia | 0.9267 | DL |
| chronic lymphocytic leukemia/small lymphocytic lymphoma with immunoglobulin heavy chain variable-region gene somatic hypermutation | 0.9239 | DL |
| pregerminal center chronic lymphocytic leukemia/small lymphocytic lymphoma | 0.9239 | DL |
| chronic myelogenous leukemia, BCR-ABL1 positive | 0.9181 | DL |
| refractory hematologic cancer | 0.9076 | DL |
| acquired secondary polycythemia | 0.9053 | DL |
| congenital secondary polycythemia | 0.8954 | DL |
| lymphoma, non-Hodgkin, familial | 0.8947 | DL |
| primary pulmonary lymphoma | 0.8878 | DL |
| primary cutaneous T-cell lymphoma | 0.8857 | DL |
| polycythemia (disease) | 0.8833 | DL |
| botryoid-type embryonal rhabdomyosarcoma of the vagina | 0.8825 | DL |
| uterine corpus sarcoma | 0.8817 | DL |
| pulmonary blastoma | 0.8814 | DL |
| well-differentiated fetal adenocarcinoma of the lung | 0.8802 | DL |
| small cell lung carcinoma | 0.8800 | DL |
| rhabdomyosarcoma (disease) | 0.8728 | DL |
| extrahepatic bile duct rhabdomyosarcoma | 0.8707 | DL |
| embryonal extrahepatic bile duct rhabdomyosarcoma | 0.8670 | DL |
| gastric linitis plastica | 0.8638 | DL |
| parameningeal embryonal rhabdomyosarcoma | 0.8616 | DL |
| prostate embryonal rhabdomyosarcoma | 0.8614 | DL |
| lymphoid neoplasm | 0.8571 | DL |
| liver sarcoma | 0.8570 | DL |
| localized pagetoid reticulosis | 0.8533 | DL |
| lymphoma | 0.8518 | DL |
| reticulum cell sarcoma | 0.8489 | DL |
| colon adenocarcinoma | 0.8421 | DL |
| myeloid/lymphoid neoplasms associated with eosinophilia and abnormality of PDGFRA, PDGFRB, FGFR1 or JAK2 | 0.8293 | DL |
| interdigitating dendritic cell sarcoma | 0.8277 | DL |
| Hodgkins lymphoma | 0.8251 | DL |
| T-cell leukemia | 0.8228 | DL |
Showing top 50 of 51 predictions.
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.